Application 080235
- Type
- ANDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | VASOCON | NAPHAZOLINE HYDROCHLORIDE | SOLUTION/DROPS;OPHTHALMIC | 0.1% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A080235-002 | VASOCON | NAPHAZOLINE HYDROCHLORIDE | 0.1% | SOLUTION/DROPS / OPHTHALMIC | 1983-03-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A080235-002 | VASOCON | 0.1% | SOLUTION/DROPS / OPHTHALMIC | 1983-03-24 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A080235-002 | VASOCON | 0.1% | SOLUTION/DROPS / OPHTHALMIC | 1983-03-24 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A080235-002 | VASOCON | 0.1% | SOLUTION/DROPS / OPHTHALMIC | 1983-03-24 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pi Yuan Chin | NAPHAZOLINE HYDROCHLORIDE | International Nature Nutraceuticals | e7aedab9-da4c-4494-a896-1e6ed2a956fe | 2025-12-27 | Warnings | NAPHAZOLINE HYDROCHLORIDE |
| NAFASOLINA | NAPHAZOLINE HYDROCHLORIDE | Doral Pharmamedics Inc DBA AG Marin Pharmaceuticals | 30cade3d-208f-8594-e063-6394a90ad2a0 | 2025-12-18 | Warnings | NAPHAZOLINE HYDROCHLORIDE |
| Nazal | NAPHAZOLINE HYDROCHLORIDE | Sato Pharmaceutical Co., Ltd. | 4d4043f8-5ed3-4027-beb6-687db1308202 | 2023-12-06 | Warnings | NAPHAZOLINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.